Form D · Other Health Care
Stolle Milk Biologics, Inc.
Cincinnati, OH · CIK 0001523680
Offering snapshot reported Jun 21, 2011 · SEC filing
- Reported sold
- Yet to sell Offering amount: $1M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 21, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $130K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-161593
Spencer Trask Ventures, Inc. is receiving a commission of 10% of the gross proceeds from the Offering, a 3% non-accountable expense allowance from the gross proceeds from the Offering, and Warrants to purchase 20% of the Units sold in the Offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None | Spencer Trask Ventures, Inc. · CRD 28373 |
Source: Form D, filed Jun 21, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Braman | Director, Executive |
| Donald Farley | Director, Executive |
| George Stagnitti | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
6954 Cornell Road, Suite 400
Cincinnati, OH, 45242
Cincinnati, OH, 45242